BoylesSH, WeberAM, MeynL.Procedures for pelvic organ prolapse in the United States, 1979-1997. Am J Obstet Gynecol2003; 188: 108–115
2.
BoylesSH, WeberAM, MeynL.Procedures for urinary incontinence in the United States, 1979-1997. Am J Obstet Gynecol2003; 189: 70–75.
3.
MantJ, PainterR, VesseyM.Epidemiology of genital prolapse: observations from the Oxford Family Planning Association study. Br J Obstet Gynaecol1997; 104: 579–585.
4.
OlsenAL, SmithVJ, BergstromJO,. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol1997; 89: 501–506.
5.
ChenB, WenY, PolanML.Elastolytic activity in women with stress urinary incontinence and pelvic organ prolapse. Neurourol Urodyn2004; 23: 119–126.
6.
DeLanceyJO, KearneyR, ChouQ,. The appearance of levator ani muscle abnormalities in magnetic resonance images after vaginal delivery. Obstet Gynecol2003; 101: 46–53.
7.
TunnR, ParisS, FischerW, HammB, KuchinkeJ.Static magnetic resonance imaging of the pelvic floor muscle morphology in women with stress urinary incontinence and pelvic prolapse. Neurourol and Urodyn1998; 17: 579–589.
8.
HoyteL, SchierlitzL, ZouK,. Two- and 3-dimensional MRI comparison of levator ani structure, volume, and integrity in women with stress incontinence and prolapse. Am J Obstet Gynecol2001; 185: 11–19.
9.
LienKC, MooneyB, DeLanceyJO, Ashton-MillerJA.Levator ani muscle stretch induced by simulated vaginal birth. Obstet Gynecol2004; 103: 31–40.
10.
AllenRE, HoskerGL, SmithARB, WarrellDW.Pelvic floor damage and childbirth: a neurophysiological study. Br J Obstet Gynaecol1990; 97: 770–779
FisherB, CostantinoJP, WickerhamDL,. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst1998; 90: 1371–1388.
13.
MaenpaaJU, Ala-FossiSL.Toremifene in postmenopausal breast cancer. Efficacy, safety and cost. Drugs Aging1997; 11: 261–270.
14.
GoldsteinSR, NevenP, ZhouL,. Raloxifene effect on frequency of surgery for pelvic floor relaxation. Obstet Gynecol2001; 98: 91–96.
15.
VardyMD, LindsayR, ScottiRJ,. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol2003; 189: 81–88.
